Leukoverine is Not a Recognized ADHD Medication
"Leukoverine" does not exist as a recognized pharmaceutical agent for ADHD or any other medical condition. This appears to be either a misspelling, confusion with another medication name, or a non-existent drug.
Possible Explanations
Leucovorin (folinic acid) is a real medication used primarily as an antidote for methotrexate toxicity and in cancer chemotherapy protocols, but it has no role in ADHD treatment and is not indicated for neuropsychiatric conditions 1.
Levoamphetamine is a component of mixed amphetamine salts (Adderall) used for ADHD, but this is not called "leukoverine" 2.
No major ADHD treatment guidelines from the American Academy of Pediatrics, American Academy of Child and Adolescent Psychiatry, or European consensus statements mention any medication resembling "leukoverine" 1, 3, 4.
Evidence-Based ADHD Treatment Options
If seeking effective ADHD treatment, the following medications are FDA-approved and guideline-recommended:
First-Line Pharmacological Treatment
Stimulant medications (methylphenidate or amphetamines) are recommended as first-line pharmacological treatment with demonstrated efficacy in 70-80% of patients and large effect sizes (1.0 for stimulants) 2, 3.
Long-acting formulations are strongly preferred due to better medication adherence, lower risk of rebound effects, and more consistent symptom control throughout the day 2.
Second-Line Non-Stimulant Options
Atomoxetine is the only FDA-approved non-stimulant for ADHD, with medium-range effect sizes (0.7) and requires 6-12 weeks to achieve full therapeutic effect 2, 4, 5.
Extended-release guanfacine or clonidine (alpha-2 adrenergic agonists) demonstrate effect sizes around 0.7 and can be useful as monotherapy or adjunctive therapy 2, 6.
Critical Clinical Pitfall
Do not prescribe or seek unrecognized medications for ADHD treatment. Stick to evidence-based, FDA-approved medications with established safety profiles and efficacy data from randomized controlled trials 1, 3, 4. The use of unproven or non-existent medications exposes patients to potential harm without any therapeutic benefit and represents a fundamental deviation from standard of care 1, 7.